Recursion Pharmaceuticals
Price & Volume
Stats
See more52W Range | $2.77-$7.18 |
Market Cap | $2B |
Shares Short | 184M |
Financials
See moreRevenue (12 Mos) | $66.4M |
Revenue Growth (YoY) | -56.1% |
Gross Profit (12 Mos) | -$428.7M |
Diluted EPS | -$1.12 |
News
See moreYahoo Finance • 6 days ago
Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?
Yahoo Finance • 9 days ago
Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance • 12 days ago
Cathie Wood buys $11.5 million of battered tech stock
Yahoo Finance • 12 days ago
Nvidia Owns This Under-the-Radar $20 Stock Poised to Disrupt a $1.8 Trillion Market
About
CEO | Dr. Najat Khan Ph.D. |
CFO | Mr. Ben R. Taylor |
Address | 41 South Rio Grande Street, Salt Lake City, UT, United States, 84101 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 600 |